Robust pharmaceutical analysis is about more than data collection. It’s about having the expertise to understand data, and to translate it into results—whether that means accelerating your R&D program, optimizing your cGMP manufacturing process, or submitting a successful NDA/ANDA application to bring a safe and effective drug to market.
Our experienced team does just that with their innovative approach to analytical services, designed to streamline regulatory approval by demonstrating your deep understanding and control of the drug product and its process development. You can leverage these analytical capabilities as standalone services, or fold them into a comprehensive drug development and manufacturing partnership with us. Either way, you’re assured of timely and high-quality results, freeing you to do your best work while we do ours.
Our specialists use state-of-the-art chromatography and spectroscopy equipment, including ICP-MS and ICP-OES, to design and validate methods that exceed the industry’s highest standards.
With three facilities in California, Colorado, and Texas, we’re ever-ready to meet even your tightest timelines and deliver the precise and client-specific analytical reporting you need.
Over 60 QA/QC/Analytical specialists and a network of cGMP-compliant facilities drive our analytical services offering, providing an unparalleled diversity of services to meet your every objective.
We provide rapid, high-quality analytical and microbiological testing for all forms of drug substances and drug products, including compound pharmacy APIs.
Our specialists use validated, on-site environmental chambers to provide the custom or ICH-mandated stability data you require, from early clinical batches to packaged drug products.